Literature DB >> 21720029

Xanthine oxidase inhibitory activities and crystal structures of methoxyflavones from Kaempferia parviflora rhizome.

Kikuyo Nakao1, Kazuya Murata, Takahiro Deguchi, Kimihisa Itoh, Takanori Fujita, Masayuki Higashino, Yuri Yoshioka, Shin-Ichi Matsumura, Rika Tanaka, Tetsuro Shinada, Yasufumi Ohfune, Hideaki Matsuda.   

Abstract

Kaempferia parviflora (KP), a Zingiberaceae plant, is used as a folk medicine in Thailand for the treatment of various symptoms, including general pains, colic gastrointestinal disorders, and male impotence. In this study, the inhibitory activities of KP against xanthine oxidase (XOD) were investigated. The extract of KP rhizomes showed more potent inhibitory activity (38% at 500 µg/ml) than those of the other Zingiberaceae plants tested. Ten methoxyflavones were isolated from the KP extract as the major chemical components and their chemical structures were elucidated by X-ray crystallography. The structurally confirmed methoxyflavones were subjected to the XOD inhibitory test. Among them, 3,5,7,4',5'-pentamethoxyflavone and 3',4',5,7-tetramethoxyflavone showed inhibitory activities (IC(50) of 0.9 and >4 mM, respectively) and their modes of inhibition are clarified as competitive/non-competitive mixed type. To the best of our knowledge, this is the first report to present the inhibitory activities of KP, 3,5,7,4',5'-pentamethoxyflavone and 3',4',5,7-tetramethoxyflavone against XOD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21720029     DOI: 10.1248/bpb.34.1143

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  8 in total

1.  New flav-3-en-3-ol glycosides, kaempferiaosides C and D, and acetophenone glycosides, kaempferiaosides E and F, from the rhizomes of Kaempferia parviflora.

Authors:  Saowanee Chaipech; Toshio Morikawa; Kiyofumi Ninomiya; Masayuki Yoshikawa; Yutana Pongpiriyadacha; Takao Hayakawa; Osamu Muraoka
Journal:  J Nat Med       Date:  2011-11-20       Impact factor: 2.343

2.  Transdermal permeation of Kaempferia parviflora methoxyflavones from isopropyl myristate-based vehicles.

Authors:  Sarunya Tuntiyasawasdikul; Ekapol Limpongsa; Napaphak Jaipakdee; Bungorn Sripanidkulchai
Journal:  AAPS PharmSciTech       Date:  2014-05-03       Impact factor: 3.246

3.  Increased vascular eNOS and cystathionine-γ-lyase protein after 6 weeks oral administration of 3, 5, 7, 3', 4'-pentamethoxyflavone to middle-aged male rats.

Authors:  Somruedee Yorsin; Kanyanatt Kanokwiroon; Nisaudah Radenahmad; Chaweewan Jansakul
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-07-28       Impact factor: 3.000

4.  Improvement in blood fluidity by Kaempferia parviflora rhizome.

Authors:  Kazuya Murata; Takahiro Deguchi; Takanori Fujita; Hideaki Matsuda
Journal:  J Nat Med       Date:  2012-12-05       Impact factor: 2.343

5.  Suppression of benign prostate hyperplasia by Kaempferia parviflora rhizome.

Authors:  Kazuya Murata; Hirotaka Hayashi; Shinichi Matsumura; Hideaki Matsuda
Journal:  Pharmacognosy Res       Date:  2013-10

Review 6.  Recent Advances in Kaempferia Phytochemistry and Biological Activity: A Comprehensive Review.

Authors:  Abdelsamed I Elshamy; Tarik A Mohamed; Ahmed F Essa; Ahmed M Abd-ElGawad; Ali S Alqahtani; Abdelaaty A Shahat; Tatsuro Yoneyama; Abdel Razik H Farrag; Masaaki Noji; Hesham R El-Seedi; Akemi Umeyama; Paul W Paré; Mohamed-Elamir F Hegazy
Journal:  Nutrients       Date:  2019-10-07       Impact factor: 5.717

7.  Antiviral activity of flavonoids present in aerial parts of Marcetia taxifolia against Hepatitis B virus, Poliovirus, and Herpes Simplex Virus in vitro.

Authors:  Joseph Thomas Ortega; María Luisa Serrano; Alírica Isabel Suárez; Jani Baptista; Flor Helene Pujol; Lucía Vicenta Cavallaro; Héctor Rodolfo Campos; Héctor Rafael Rangel
Journal:  EXCLI J       Date:  2019-11-05       Impact factor: 4.068

8.  Improved dissolution of Kaempferia parviflora extract for oral administration by preparing solid dispersion via solvent evaporation.

Authors:  Yotsanan Weerapol; Sukannika Tubtimsri; Chaweewan Jansakul; Pornsak Sriamornsak
Journal:  Asian J Pharm Sci       Date:  2016-11-04       Impact factor: 6.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.